SPRING BIOLAB AS

Keywords

researchdevelopment workbiotechnologygenomicspharmageneticsgene samplesdna sequencingdna synthesisdna deepeninggenetic engineeringproteinsmoleculespeptide sequencinglipidglycotechniqueproteomicshormonesgrowth factorscell receptorspheromonescell culturetissue culturecrossingcell fusionvaccineimmunostimulatorsembryo manipulationprocess biotechnologybioreactorsfermentationbioprocessingbiorecoverybiodesulfurizationbiological pulp productionbiofiltrationbiological regenerationsubcellular organismsgene therapyvirusesvectors

Organization

CEO: SS
Sergey Shaposhnikov1974
Chairman of the board: SS
Sergey Shaposhnikov1974
Years since formation: 1 year; since Nov 10, 2023
Type: Limited company
VAT registered: Yes
Number of employees: 0

Ownership

Number of shares and share classes: 3,000; 1 share class
Total number of shareholders: 3; persons

Last update: Aug 29, 2024

Management

Management / administration

Name	Role	Shares
SS Sergey Shaposhnikov 1974	Managing Director/CEO	90 % directly

Board

Name	Role	Shares
SS Sergey Shaposhnikov 1974	Chairman	90 % directly
HD Hildegunn Dahl 1981	Board Member	-

Others

Name	Role	Shares
I I M RUUD REGNSKAP AS	Accountant	-

Top 10 individual shareholders

Name	Role	Shares
SS Sergey Shaposhnikov 1974	Chairman, Managing Director/CEO	90 % directly
GB Gunnar Brunborg 1947	-	9 % directly
AR Andrew Richard Sherman Collins 1946	-	1 % directly

Last update: Jan 16, 2024

Ownership

Company shareholders

Name	Share class	Number of shares	Share
SS Sergey Shaposhnikov 1974	Ordinary shares	2,700	90 %
GB Gunnar Brunborg 1947	Ordinary shares	270	9 %
AR Andrew Richard Sherman Collins 1946	Ordinary shares	30	1 %

Last update: May 24, 2024

Financials

in NOK

No available data

SPRING BIOLAB AS932 435 942

SPRING BIOLAB AS

Keywords

Organization

Ownership

Management

Management / administration

Board

Others

Top 10 individual shareholders

Ownership

Company shareholders

Financials

Classification